Dihydroergotamine interaction with 5-HT2 receptors and its relevance to migraine
pp 194-198 dans “Preventive Pharmacotherapy of Headache Disorders” de J. Olesen, SD. Silberstein and P. Tfelt-Hansen édité par Oxford University Press.
Schaerlinger B., Hickel P., Etienne N., Guesnier L., Maroteaux L.